PMID

Data

Article Title

Organization

Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists.

James Black Foundation

Optimization of 1,3,4-benzotriazepine-based CCK(2) antagonists to obtain potent, orally active inhibitors of gastrin-mediated gastric acid secretion.

James Black Foundation

Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists.

James Black Foundation

Development of peptide 3D structure mimetics: rational design of novel peptoid cholecystokinin receptor antagonists.

James Black Foundation

Rationalizing the activities of diverse cholecystokinin 2 receptor antagonists using molecular field points.

James Black Foundation

Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists.

James Black Foundation

2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a new template for the design of CCK(2) receptor antagonists.

James Black Foundation

Non-peptide cholecystokinin-B/gastrin receptor antagonists based on bicyclic, heteroaromatic skeletons.

James Black Foundation

Improving the affinity and selectivity of a nonpeptide series of cholecystokinin-B/gastrin receptor antagonists based on the dibenzobicyclo[2.2.2]octane skeleton.

James Black Foundation

A new class of non-peptidic cholecystokinin-B/gastrin receptor antagonists based on dibenzobicyclo[2.2.2]octane.

James Black Foundation